Krystal Biotech, Inc. (KRYS) Debt Components
- 2017-12-31: Convertible Notes PayableUSD $0.00; Long-term DebtUSD (m); Long-term Debt, GrossUSD (m); Notes Payable, Related Parties, NoncurrentUSD $0.00.
- 2017-09-30: Convertible Notes PayableUSD $0.00; Long-term DebtUSD (m); Long-term Debt, GrossUSD (m); Notes Payable, Related Parties, NoncurrentUSD $0.00.
- 2017-08-08: Convertible Notes PayableUSD (m); Long-term DebtUSD $4.25M; Long-term Debt, GrossUSD $4.14M; Notes Payable, Related Parties, NoncurrentUSD (m).
- 2016-12-31: Convertible Notes PayableUSD $1.80M; Long-term DebtUSD (m); Long-term Debt, GrossUSD (m); Notes Payable, Related Parties, NoncurrentUSD $698.00K.
Krystal Biotech, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable USD | Long-term Debt USD | Long-term Debt, Gross USD | Notes Payable, Related Parties, Noncurrent USD |
|---|---|---|---|---|
| 2017-12-31 | $0.00 | (m) | (m) | $0.00 |
| 2017-09-30 | $0.00 | (m) | (m) | $0.00 |
| 2017-08-08 | (m) | $4.25M | $4.14M | (m) |
| 2016-12-31 | $1.80M | (m) | (m) | $698.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |